Class Action InvestigationsZantac Class ActionZantac and Cancer Link: What You Need to Know

November 6, 2020by Shamis & Gentile P.A.
https://www.sflinjuryattorneys.com/wp-content/uploads/2020/10/cancer.jpg

Have you or a loved one been diagnosed with bladder cancer, stomach cancer or breast cancer following the usage of Zantac or other ranitidine heartburn medications?

If so, then you may be eligible to participate in a Zantac lawsuit investigation.

On April 1st, 2020, the FDA released a statement calling for the recall of all Zantac and ranitidine medications, including both OTC and prescription varieties. The FDA indicated that these recall was due to the fact that a known carcinogen, NDMA, was found in tested batches of Zantac medication.

The FDA recall of 2020 follows several voluntary recalls by the makers of Zantac, along with the makers of generic ranitidine medications, due to the presence of an “unexpected impurity … NDMA.” NDMA refers to N-Nitrosodimethylamine, which is considered a known carcinogen which is linked to the development of cancer.

What is Zantac Used For?

Zantac and similar ranitidine medications were typically prescribed as heartburn medications. Zantac is an H2 blocker which reduces the production of acid in the stomach. Zantac could be prescribed or purchased over the counter in certain doses. The most common dosages of Zantac are 75 and 150 mg tablets, though some people take 300 mg of Zantac per day. Zantac is the 50th most prescribed drug in the United States with about 15 million prescriptions written yearly; this does not include over the counter purchases.

Other Side Effects of Zantac

In addition to the aforementioned cancer link, other serious side effects have been associated with Zantac. These side effects include rhabdomylosis, a musculo-skeletal disease which can lead to kidney damage or failure; chronic kidney disease and kidney failure even without rhabdomylosis; osteoporosis; and even intestinal infections.

Zantac and Cancer Link

The presence of NDMA in Zantac was found to be at extremely elevated levels; an independent lab study found that there was about 3,000 times the daily maximum intake recommended by the FDA in a single Zantac 150 mg tablet. NDMA is associated with a heightened cancer risk due to the fact that it is classified as a probable carcinogen.

Zantac Lawsuit Lawyers: Should You Join a Lawsuit?

There have already been some Zantac lawsuit investigation actions filed. One such investigation was filed against Sanofi, the drugmaker for Zantac; this lawsuit stated that they believed Sanofi was obligated to disclose the potential for contamination and inform consumers of their product about the risk.

As awareness regarding the potential link between Zantac and cancer grows, more people are consulting with professional Zantac lawsuit lawyers about their options. If you or a loved one took Zantac regularly and were later diagnosed with cancer, then you may be eligible for compensation. We are working hard to fight for anyone who is eligible under a Zantac lawsuit investigation; compensation may include compensation for medical bills, physical and mental anguish, lost wages, and lost earning potential.

Contact Zantac Lawyers Today

Did you take Zantac and were you later diagnosed with one or more types of cancer? If so, you may be entitled to a lawsuit investigation or settlement. Contact your Zantac Lawyers, Shamis & Gentile, P.A. for a completely free case review at info@shamisgentile.com; or you can call us today 305-479-2299.

Pin It on Pinterest

Share This